What Should Vaccine Developers Ask? Simulation of the Effectiveness of Malaria Vaccines
2008

Simulation of Malaria Vaccines

publication Evidence: moderate

Author Information

Author(s): Penny Melissa A., Maire Nicolas, Studer Alain, Schapira Allan, Smith Thomas A.

Primary Institution: Swiss Tropical Institute, Basel, Switzerland

Hypothesis

What should vaccine developers ask regarding the effectiveness of malaria vaccines?

Conclusion

The study presents a stochastic simulation approach to compare the effects of various malaria vaccines on morbidity, mortality, and transmission.

Supporting Evidence

  • Moderately efficacious pre-erythrocytic vaccines do not substantially affect malaria transmission.
  • High efficacy pre-erythrocytic vaccines can achieve herd immunity when delivered via mass vaccination.
  • Blood-stage vaccines are more effective in high transmission settings compared to pre-erythrocytic vaccines.
  • Combination vaccines generally perform similarly to the best individual components.

Takeaway

This study uses computer models to predict how well different malaria vaccines might work in real life, helping researchers decide which vaccines to develop.

Methodology

The study used stochastic simulation models calibrated against epidemiological data to predict the effects of malaria vaccines.

Limitations

The models do not account for immigration and importation of new cases, which may not reflect real-life situations.

Digital Object Identifier (DOI)

10.1371/journal.pone.0003193

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication